PFBT
KRTX

Parkside Financial Bank & Trust’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$634 – 2112
2023
Q4 		$634 Buy
2
+1
+100% +$194 ﹤0.01% 1706
2023
Q3 		$170 Hold
1
– – ﹤0.01% 1996
2023
Q2 		$217 Buy
+1
New +$214 ﹤0.01% 1961

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Parkside Financial Bank & Trust's KRTX Position: Q1 2024 in Review

Parkside Financial Bank & Trust sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2 shares — an estimated $634 sold.

Parkside Financial Bank & Trust first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $634 in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Parkside Financial Bank & Trust reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 2 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $634.
  • Parkside Financial Bank & Trust first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Parkside Financial Bank & Trust's Karuna Therapeutics, Inc. Common Stock position peaked at $634 in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2024, filed 1 May 2024.